Skip to content

Clinical trials

Phase 1 Leukemia, Myelomonocytic, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Phase: Phase 1 Clear all

157 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20013
20025
20034
20048
20055
20066
20078
20085
20092
20105
20113
20126
20133
20142
20151
20164
20176
20186
20197
202010
20216
20227
20237
20243
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed99
Terminated22
Recruiting17
Active, not recruiting10
Withdrawn4
Unknown status4
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)20
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins12
M.D. Anderson Cancer Center11
Fred Hutchinson Cancer Center7
Memorial Sloan Kettering Cancer Center5
Mayo Clinic4
Astex Pharmaceuticals, Inc.3
Celgene3
Dana-Farber Cancer Institute3
Massachusetts General Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic157
Leukemia, Myeloid, Acute123
Myelodysplastic Syndromes104
Precursor Cell Lymphoblastic Leukemia-Lymphoma71
Leukemia57
Myeloproliferative Disorders57
Leukemia, Lymphocytic, Chronic, B-Cell54
Primary Myelofibrosis50
Blast Crisis43
Multiple Myeloma40

Trials

Showing 76 to 100 of 157. Each trial links to its page on Pharma Observatory.

57 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.